Comparing Daridorexant vs Dayvigo
Daridorexant | Dayvigo (lemborexant) |
|
---|
Daridorexant | Dayvigo (lemborexant) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Insomnia. Daridorexant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
|||||||
More about Daridorexant | More about Dayvigo (lemborexant) | ||||||||
Ratings & Reviews | |||||||||
Daridorexant has an average rating of 5.3 out of 10 from a total of 163 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 44% reported a negative effect. |
Dayvigo has an average rating of 5.1 out of 10 from a total of 270 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Daridorexant side effects |
View all Dayvigo side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dayvigo prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Quviviq |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
8 hours |
19 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 679 drugs are known to interact with Daridorexant:
|
A total of 463 drugs are known to interact with Dayvigo:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 07, 2022 |
December 20, 2019 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.